The Outcome of Hydroxychloroquine in Patients Treated for COVID-19: Systematic Review and Meta-Analysis.
Conclusion: This meta-analysis and systematic review, which included a limited number of poorly designed studies of patients with COVID-19, revealed HCQ is intolerable, unsafe, and not efficacious. Similarly, HCQ + AZ combination was not different from HCQ alone in curbing mortality and ICU admission.
PMID: 33082891 [PubMed - in process]
Source: Respiratory Care - Category: Respiratory Medicine Authors: Ayele Mega T, Feyissa TM, Dessalegn Bosho D, Kumela Goro K, Zeleke Negera G Tags: Can Respir J Source Type: research
More News: Azithromycin | Coronavirus | COVID-19 | Databases & Libraries | Hydroxychloroquine | Intensive Care | International Medicine & Public Health | Pandemics | Respiratory Medicine | SARS | Science | Study | Virology | Zithromax